Ocular Hypertension Treatment Study (OHTS)
NCT00803998 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2013-11-01
Summary
The Ocular Hypertension Treatment Study is a multi-center clinical trial sponsored by the National Eye Institute, designed to determine the efficacy and safety of topically administered eye lowering medication
Conditions
Sponsors & Collaborators
-
National Eye Institute (NEI)
collaborator NIH -
The New York Eye & Ear Infirmary
lead OTHER
Principal Investigators
-
Michael Kass, MD · Washington University School of Medicine at St. Louis, St. Louis, Missouri
Eligibility
- Min Age
- 40 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1994-02-28
- Completion
- 2006-12-31
More Related Trials
-
Safety & Efficacy of Pilocarpine Eye Solutions for Temporary Improvement of Near Vision in Presbyopic Adults
NCT04657172 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia
NCT05728944 ·Status: COMPLETED ·Phase: PHASE3
-
Red Light Intervention on Myopic Progression
NCT05203432 ·Status: UNKNOWN ·Phase: NA
-
Study of OT-101 in Treating Myopia
NCT04770610 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients
NCT00884039 ·Status: TERMINATED ·Phase: NA
-
Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults
NCT05114486 ·Status: COMPLETED ·Phase: PHASE3
-
Pilocarpine and Brimonidine in Patients With Monofocal Lenses
NCT03825081 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Low-Dose Atropine for Treatment of Myopia
NCT03334253 ·Status: COMPLETED ·Phase: PHASE3
-
Low Concentration Atropine in the Prevention of Myopia in Children.
NCT05939882 ·Status: UNKNOWN ·Phase: NA
-
the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression
NCT06034366 ·Status: UNKNOWN ·Phase: NA
-
A Study of Safety and Efficacy of UNR844 Chloride (UNR844-Cl) Eye Drops in Subjects With Presbyopia.
NCT03809611 ·Status: COMPLETED ·Phase: PHASE2
-
Investigational Study of Accommodation Triggering and Control to Allow for the Performance of Refraction Measurements
NCT03957408 ·Status: COMPLETED ·Phase: NA
-
Systemic Erythropoietin Injection in Patients Having Optic Atrophy
NCT04680143 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparing Vision Tests in a Virtual Reality Headset to Existing Analogues
NCT04714424 ·Status: COMPLETED
-
Study of a Hand-held Device Plus Mobile App Versus Standard Eye Care Devices in Measuring Refractive Error of the Eye
NCT03929588 ·Status: COMPLETED ·Phase: NA
-
Enhancement of Emmetropization in Hyperopic Infants
NCT00574717 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
OCT in Diagnosis of Irregular Corneas
NCT03504800 ·Status: RECRUITING
-
A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
NCT03201562 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1/2 Crossover Study to Assess EXP039 for Myopia or Hyperopia
NCT04883996 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Retinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retinitis Pigmentosa
NCT01530659 ·Status: COMPLETED ·Phase: PHASE2
-
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
NCT01243931 ·Status: RECRUITING ·Phase: NA
-
Initial Evaluation of Photorefractive Keratectomy in U.S. Army Personnel
NCT00413673 ·Status: COMPLETED ·Phase: NA
-
Pilot Study to Assess the Efficacy of Short Exposure to Defocus to Slow the Progression of Myopia in Children
NCT00400140 ·Status: COMPLETED ·Phase: NA
-
Hyperopia Treatment Study 1 (HTS1) - Glasses vs Observation
NCT01515475 ·Status: COMPLETED ·Phase: NA
-
The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression
NCT06708156 ·Status: RECRUITING ·Phase: PHASE3